Replies to post #244215 on NorthWest Biotherapeutics Inc (NWBO)

[alexander77]

Let’s just wait for the SAP being approved and in the meanwhile we can buy more shares.
Don’t forget ASCO 2019 (on DCVAX-L):
Follow-up survival data from the Information Arm patients who did not qualify for the Phase III trial are encouraging and appear consistent with the blinded interim data from the trial. In the group of 25 Information Arm patients who had actual or apparent early tumor recurrence, the follow-up data showed that 40% of the patients lived for 3 years or more, 20% of the patients lived for 5 years or more, and 12% of the patients are still alive at 7 years.

This Information Arm survival data is especially encouraging since this group included patients who already had actual tumor recurrence as well as others who had the appearance of tumor recurrence but who could not be definitely determined. ”

[Poor Man -]

BSB, I think you hit on the other problem of Linda and Les creating an enormous amount of uncertainty through their lack of communication and transparency, which also deters investors.

[joeycav11]

Unless Linda not talking because a partnership with big pharma is happening, and big pharma told her to not say a word until topline